Nuclear Medicine in Cancer Management:    Improving Efficacy and Reducing Costs	
An AIPES Symposium

www.aipessymposium.eu       www.aipes-eeig.org       2016

Wednesday 16 September 2015

Théâtre du Vaudeville, Brussels


Molecular Imaging is in a key position to bring personalized therapy into routine clinical practice. It can provide non-invasive tools to monitor and predict response to therapy, leading to improved quality of life while, at the same time, reduces healthcare costs.  


AIPES cordially invites you to attend the 2015 Symposium where the opinion leaders, listed below, will present their experience and evidence on how patient management could be improved within the current constraints of the global economic climate. An open round-table discussion with the audience will follow.

Download the complete programme


Invited speakers:

  1. Wolfgang Weber, MD, Memorial Sloan Kettering Cancer Center,

  New York, USA

• Barry A. Siegel, MD, Mallinckrodt Institute of Radiology,

  Washington University School of Medicine,

  St. Louis, Missouri, USA,

  1. Elisabeth de Vries, MD, PhD, Faculty of

  Medical Sciences,

  Medical Oncology,  Groningen, The Netherlands,

  1. Barbara Malene Fischer, MD, PhD, DMSci, Dept. of Clinical
    Physiology, Nuclear Medicine and PET, Rigshospitalet,

  University of Copenhagen, Denmark.


Moderators:

• Konrade von Bremen, MD, Inselspital, Bern, Switzerland,

• Antonis Kalemis, PhD, MBA, AIPES

An initiative of the

New Technologies Working Group 

Press release

Speakers’ bio

Barbara Malene Fischer’s presentation

Barry A. Siegel’s presentation

Download documents :